Pediatric Non-Alcoholic Fatty Liver Disease

Area of Science:

• Hepatology
• Pediatric Gastroenterology
• Metabolic Disorders

Background:

• Non-alcoholic fatty liver disease (NAFLD) is increasingly prevalent in children, linked to rising obesity rates.
• NAFLD pathophysiology is complex, involving multiple pathways beyond the initial 'two-hit' hypothesis.
• Non-alcoholic steatohepatitis (NASH), a severe form of NAFLD, elevates the risk of advanced liver disease.

Purpose of the Study:

• To review the current understanding of NAFLD pathophysiology in pediatric patients.
• To highlight the extrahepatic manifestations and long-term risks associated with pediatric NAFLD.
• To emphasize the need for further research into the natural history of NAFLD in children.

Main Methods:

• Literature review of existing studies on pediatric NAFLD.
• Analysis of current data on NAFLD pathophysiology and clinical outcomes.
• Synthesis of information regarding extrahepatic complications and long-term prognosis.

Main Results:

• Pediatric NAFLD is a significant cause of chronic liver disease, driven by obesity.
• NAFLD involves complex multifactorial pathways and is associated with significant co-morbidities.
• Increased long-term mortality and liver transplantation rates are projected for pediatric NAFLD patients.

Conclusions:

• Pediatric NAFLD is a growing public health concern with serious implications.
• The disease extends beyond the liver, affecting multiple organ systems.
• Further research is crucial to elucidate the natural history and optimize management of NAFLD in children.